Outcome Measurement in Clinical Genetics Services: A Systematic Review of Validated Measures

Coventry, 1999, From what and why did genetics emerge as a medical specialism in the 1970s in the UK? A case-history of research, policy and services in the Manchester region of the NHS, Soc Sci Med, 49, 1227, 10.1016/S0277-9536(99)00162-8 Fraser, 1975, Genetic counselling, Am J Hum Genet, 27, 240 Donnai, 2002, Genetic services, Clin Genet, 61, 1, 10.1034/j.1399-0004.2002.610101.x Acquadro, 2001, Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, Value Health, 6, 522, 10.1046/j.1524-4733.2003.65309.x Carlson, 2005, Economic analysis of human genetics services: a systematic review, Genet Med, 7, 519, 10.1097/01.GIM.0000182467.79495.e2 Jarrett, 2006, Genetic health technology and economic evaluation. A critical review, Appl Health Econ Health Policy, 5, 27, 10.2165/00148365-200605010-00004 Wang, 2004, Assessment of genetic testing and related counselling services: current research and future directions, Soc Sci Med, 58, 1427, 10.1016/S0277-9536(03)00337-X Royal College of Physicians, 1998 Royal College of Physicians, 1998 Clarke, 1997, Outcomes and process in genetic counselling, Clin Genet, 50, 462, 10.1111/j.1399-0004.1996.tb02713.x MacLeod R. The genetic counselling process: an interpretative phenomenological analysis of patient–counsellor interactions. PhD Thesis, The University of Manchester, 2003. Bernhardt, 2000, Goals, benefits and outcomes of genetic counselling: client and genetic counsellor assessment, Am J Med Genet, 94, 189, 10.1002/1096-8628(20000918)94:3<189::AID-AJMG3>3.0.CO;2-E Biesecker, 2001, Process studies in genetic counselling: peering into the black box, Am J Med Genet, 106, 191, 10.1002/ajmg.10004 Bekker, 1999, Informed decision making: an annotated bibliography and systematic review, Health Tech Assess, 3, 1, 10.3310/hta3010 Meiser, 2002, What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review, Soc Sci Med, 54, 1463, 10.1016/S0277-9536(01)00133-2 Vadaparampil, 2005, Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers, Fam Cancer, 4, 195, 10.1007/s10689-004-1446-7 Katapodi, 2004, Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review, Prev Med, 3, 388, 10.1016/j.ypmed.2003.11.012 Bowen, 2002, Effects of risk counselling on interest in breast cancer genetic testing for lower risk women, Genet Med, 4, 359, 10.1097/00125817-200209000-00007 Brain, 1999, Anxiety and adherence to breast self-examination in women with a family history of breast cancer, Psychosom Med, 61, 181, 10.1097/00006842-199903000-00010 Brain, 2000, Randomized trial of a specialist genetic assessment service for familial breast cancer, J Natl Cancer Inst, 92, 1345, 10.1093/jnci/92.16.1345 Brain, 2005, An exploratory comparison of genetic counselling protocols for HNPCC predictive testing, Clin Genet, 68, 255, 10.1111/j.1399-0004.2005.00491.x Cederholm, 1999, Women's knowledge, concerns and psychological reactions before undergoing an invasive procedure for prenatal karyotyping, Ultrasound Obstet Gynecol, 14, 267, 10.1046/j.1469-0705.1999.14040267.x Berkenstadt, 1999, Perceived personal control (PPC): a new concept in measuring outcome of genetic counselling, Am J Med Genet, 82, 53, 10.1002/(SICI)1096-8628(19990101)82:1<53::AID-AJMG11>3.0.CO;2-# Collins, 2005, Screening and preventive behaviors one year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma, Cancer, 104, 273, 10.1002/cncr.21183 Dorval, 2000, Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs, J Clin Oncol, 18, 2135, 10.1200/JCO.2000.18.10.2135 Drake, 1999, Development and evaluation of a decision aid about prenatal testing for women of advanced maternal age, J Genet Couns, 8, 217, 10.1023/A:1022998415890 Stalmeier, 1999, Evaluation of a shared decision making program for women suspected to have a genetic predisposition to breast cancer: preliminary results, Med Decis Making, 19, 230, 10.1177/0272989X9901900302 Trask, 2001, Cancer-specific worry interference in women attending a breast and ovarian cancer risk evaluation program: impact on emotional distress and health functioning, Psychooncology, 10, 349, 10.1002/pon.510 Biesecker, 2000, Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families, Am J Med Genet, 93, 257, 10.1002/1096-8628(20000814)93:4<257::AID-AJMG1>3.0.CO;2-8 Decruyenaere, 1995, Predictive testing for Huntington's disease: risk perception, reasons for testing and psychological profile of test applicants, Genet Couns, 6, 1 Decruyenaere, 1999, Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease, J Med Genet, 36, 897 Fries, 2004, Outcome of five years of accelerated surveillance in patients at high risk for inherited breast/ovarian cancer: report of a phase II trial, Mil Med, 169, 411, 10.7205/MILMED.169.6.411 Grosfeld, 2000, Parents' responses to disclosure of genetic test results of their children, Am J Med Genet, 94, 316, 10.1002/1096-8628(20001002)94:4<316::AID-AJMG10>3.0.CO;2-N Michie, 1997, Information recall in genetic counselling: a pilot study of its assessment, Patient Educ Couns, 32, 93, 10.1016/S0738-3991(97)00068-2 Schwartz, 2003, Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing, J Clin Oncol, 21, 4034, 10.1200/JCO.2003.01.088 Kromberg, 1999, Utilisation of predictive, prenatal and diagnostic testing for Huntington's disease in Johannesburg, S Afr Med J, 89, 774 Miller, 2005, Facilitating informed decision making about breast cancer risk and genetic counselling among women calling the NCI's Cancer Information Service, J Health Commun, 10, 119, 10.1080/07366290500265335 Wolraich, 1985, Medical Communication Behaviour System. An interactional analysis system for medical interactions, Med Care, 24, 891, 10.1097/00005650-198610000-00003 Ambros, 2003, Quality assessment of genetic markers used for therapy stratification, J Clin Oncol, 21, 2077, 10.1200/JCO.2003.03.025 Andersson, 1995, Diagnosis of acute intermittent porphyria in northern Sweden: an evaluation of mutation analysis and biochemical methods, J Intern Med, 237, 301, 10.1111/j.1365-2796.1995.tb01179.x Chamberlain, 1992, Diagnosis of Duchenne and Becker muscular dystrophies by polymerase chain reaction: a multicenter study, J Am Med Assoc, 267, 2609, 10.1001/jama.1992.03480190051030 Taylor, 2003, Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA, Hum Mutat, 22, 428, 10.1002/humu.10291 Cabana, 1998, Consequences of the delayed diagnosis of ataxia-telangiectasia, Pediatrics, 102, 98, 10.1542/peds.102.1.98 Christianson, 1995, Mid-pregnancy genetic terminations of pregnancy–postnatal assessment and management, S Afr Med J, 85, S1084 Park, 2002, Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study, Int J Colorectal Dis, 17, 109, 10.1007/s003840100348 Ward, 1991, Measurement precision and reliability in craniofacial anthropometry: implications and suggestions for clinical applications, J Craniofac Genet Dev Biol, 11, 156 Kim, 2002, Parental decisions of pre-natally detected sex chromosome abnormality, J Korean Med Sci, 17, 53, 10.3346/jkms.2002.17.1.53 Modell, 2001, A national register for surveillance of inherited disorders: beta thalassaemia in the United Kingdom, Bull World Health Organ, 79, 1006 Donovan, 2000, Knowledge about genetic risk for breast cancer and perceptions of genetic testing in a socio-demographically diverse sample, J Behav Med, 23, 15, 10.1023/A:1005416203239 Marshall, 2000, Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia, Br J Psychiatry, 176, 249, 10.1192/bjp.176.3.249 Michie, 1997, Patient decision making: an evaluation of two different methods of presenting information about a screening test, Br J Health Psychol, 2, 317, 10.1111/j.2044-8287.1997.tb00545.x Stalmeier, 2005, The decision evaluation scales, Patient Educ Couns, 57, 286, 10.1016/j.pec.2004.07.010 O'Connor, 1995, Validation of a decisional conflict scale, Med Decis Mak, 15, 25, 10.1177/0272989X9501500105 Bunn, 1996, Validation of client decision-making instruments in the context of psychiatry, Can J Nurs Res, 28, 13 Ondrusek, 1999, Development of a knowledge scale about breast cancer and heredity (BCHK), Breast Cancer Res Treat, 53, 69, 10.1023/A:1006114710328 Lerman, 1996, BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes, JAMA, 275, 1885, 10.1001/jama.1996.03530480027036 Furr, 1999, The genetic knowledge index: developing a standard measure of genetic knowledge, Genet Test, 3, 193, 10.1089/gte.1999.3.193 Braitman, 1978, Development of instruments to measure counselees' knowledge of Down syndrome, Clin Genet, 13, 25, 10.1111/j.1399-0004.1978.tb04126.x Goel, 1996, Evaluating patient's knowledge of maternal serum screening, Prenat Diagn, 16, 425, 10.1002/(SICI)1097-0223(199605)16:5<425::AID-PD874>3.0.CO;2-2 Averill, 1973, Perceived control over aversive stimuli and its relationship to stress, Psychol Bull, 80, 286, 10.1037/h0034845 Read, 2005, Design and psychometric evaluation of the Psychological Adaptation to Genetic Information Scale, J Nurs Scholarsh, 37, 203, 10.1111/j.1547-5069.2005.00036.x Westbrook, 1979, A classification of coping behaviour based on multidimensional scaling of similarity ratings, J Clin Psychol, 35, 407, 10.1002/1097-4679(197904)35:2<407::AID-JCLP2270350236>3.0.CO;2-P Van Oostrum, 2003, Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study, J Clin Oncol, 21, 3867, 10.1200/JCO.2003.10.100 Mesters, 1997, Openness to discuss cancer in the nuclear family: scale, development and validation, Pychosom Med, 59, 269, 10.1097/00006842-199705000-00010 Moos, 1994 Erblich, 2005, Development and validation of a Breast Cancer Genetic Counselling Knowledge Questionnaire, Patient Educ Couns, 56, 182, 10.1016/j.pec.2004.02.007 Keller, 2002, Comprehensive genetic counselling for families at risk for HNPCC: impact on distress and perceptions, Genet Test, 6, 291, 10.1089/10906570260471822 Cella, 1993, The functional assessment of cancer therapy scale: development and validation of the general measure, J Clin Oncol, 11, 570, 10.1200/JCO.1993.11.3.570 Brady, 1997, Reliability and validity of the functional assessment of cancer therapy-breast quality of life instrument, J Clin Oncol, 15, 974, 10.1200/JCO.1997.15.3.974 Schwartz, 2004, Impact of BRCA1/BRCA2 counselling and testing on newly diagnosed breast cancer patients, J Clin Oncol, 22, 1823, 10.1200/JCO.2004.04.086 Schwartz, 2005, Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients, Cancer Epidemiol Biomarkers Prev, 14, 1003, 10.1158/1055-9965.EPI-03-0545 Dazord, 1995, Quality of life assessment in medicine: presentation of a new instrument (Subjective Quality of Life Profile (SQLP)) and first results, Eur Respir Rev, 5, 66 Freyer, 1999, Psychosocial impact of genetic testing in familial medullary-thyroid carcinoma: a multicentric pilot-evaluation, Ann Oncol, 10, 87, 10.1023/A:1008349318728 Wolf, 1978, Medical Interview Satisfaction Scale: development of a scale to measure patient perceptions of physician behaviour, J Behav Med, 1, 391, 10.1007/BF00846695 Holmes-Rovner, 1996, Patient satisfaction with healthcare decisions: the satisfaction with decision scale, Med Decis Making, 15, 58, 10.1177/0272989X9601600114 Pieterse, 2005, QUOTE-gene (ca): development of a counselee-centred instrument to measure needs and preferences in genetic counselling for hereditary cancer, Psychooncology, 14, 361, 10.1002/pon.853 Rosenberg, 1965 Ellison, 1991, Towards an integrative measure of health and well-being, J Psychol Theol, 19, 35, 10.1177/009164719101900104 Miller, 1987, Monitoring and blunting: validation of a questionnaire to assess styles of information seeking under threat, J Pers Soc Psychol, 52, 345, 10.1037/0022-3514.52.2.345 Barron, 1953, An ego-strength scale which predicts response to psychotherapy, J Consult Psychol, 17, 327, 10.1037/h0061962 Scheier, 1994, Distinguishing optimism from neuroticism (and Trait anxiety, self-mastery and self-esteem): a re-evaluation of the Life Orientation Test, J Pers Soc Psychol, 67, 1063, 10.1037/0022-3514.67.6.1063 National Institute for Health and Clinical Excellence, 2004 McAllister, 2006, Process and outcome in clinical genetics services: a new model developed from qualitative research, J Med Genet, 43, S62